Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Qilu Pharmaceutical
Pharmaceutical Preparation ManufacturingChina
Last verified 2 months agoqilu-pharma.com
Qilu Pharmaceutical Co., Ltd., commonly known as Qilu Pharma, is a prominent player in the pharmaceutical preparation manufacturing industry, headquartered in Jinan, Shandong Province, China. Established in 1992, the company has made significant strides in developing innovative medicines and healthcare solutions, focusing on areas such as oncology, cardiovascular health, and anti-infectives.
With a robust portfolio of core products, Qilu Pharma stands out for its commitment to quality and research-driven development. The company has achieved notable milestones, including the establishment of state-of-the-art manufacturing facilities and a strong presence in both domestic and international markets. Recognised for its contributions to the pharmaceutical sector, Qilu Pharma continues to enhance its market position through strategic partnerships and a dedication to advancing healthcare.
23
DitchCarbon score
-19 vs industry average
Qilu Pharmaceutical’s score of 23 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Qilu Pharmaceutical?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very High
Pharmaceutical Preparation Manufacturing is among the most carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Qilu Pharmaceutical yet.
Qilu Pharmaceutical's reported carbon emissions
Qilu Pharmaceutical, a company based in China within the Pharmaceutical Preparation Manufacturing industry, has provided information regarding its climate commitments. As no specific emissions data in kg CO2e has been provided for the most recent year, the company's climate initiatives are detailed. Qilu Pharmaceutical is a merged entity, inheriting data from its source organisation, Qilu Pharmaceutical Co. Ltd.
Assessing Qilu Pharmaceutical as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Qilu Pharmaceutical and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Qilu Pharmaceutical’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Qilu Pharmaceutical yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Qilu Pharmaceutical2 months ago
23
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more